i figure a small parcel making up 1-2% of my portfolio its a good punt:
- its got a beaten down sp
- a positive catalyst due shortly in the ce mark
- genuinely innovative product in an area of need
- good preliminary data
- phase 2 studies starting shortly
- strong institutional affiliations in usa/ uk
worse case scenario, it doesnt get the ce mark yet and drops a few more cents
best case, its the next sirtex (long shot but not out of the question) or a takeover target for a bigger biotech/ pharma
Commencing coverage, page-15
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
0.001(4.00%) |
Mkt cap ! $49.19M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.4¢ | 1.2¢ | $176.4K | 13.57M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 5353143 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 493343 | 1 |
View Market Depth
| Last trade - 15.45pm 13/09/2024 (20 minute delay) ? |
| OSL (ASX) Chart |